• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Advisor Biotechnology Fund

+ Add to Watchlist

FBTAX:US

24.63 USD 0.33 1.36%

As of 09:29:30 ET on 11/26/2014.

Snapshot for Fidelity Advisor Biotechnology Fund (FBTAX)

Year To Date: +29.99% 3-Month: +9.63% 3-Year: +48.05% 52-Week Range: 17.56 - 24.33
1-Month: +3.93% 1-Year: +32.69% 5-Year: +31.63% Beta vs MXWO: 1.17

Mutual Fund Chart for FBTAX

No chart data available.
  • FBTAX:US 24.30
  • 1M
  • 1Y
Interactive FBTAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBTAX

Fidelity Advisor Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-27-2000 Telephone: 1-877-208-0098
Managers: RAJIV KAUL
Web Site: advisor.fidelity.com

Fundamentals for FBTAX

NAV (on 2014-11-25) 24.30
Assets (M) (on 2014-10-31) 1,955.86
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBTAX

Dividend Type Long Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-09-05) 0.18
Dividend Yield (ttm) 0.97

Fees & Expenses for FBTAX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 0.25
Expense Ratio 1.08

Top Fund Holdings for FBTAX

Filing Date: 09/30/2014
Name Position Value % of Total
Gilead Sciences Inc 2,181,937 232,267,194 13.330%
Celgene Corp 1,323,725 125,462,656 7.200%
Vertex Pharmaceuticals Inc 904,326 101,564,853 5.829%
Alexion Pharmaceuticals Inc 468,799 77,736,250 4.461%
Regeneron Pharmaceuticals Inc 212,100 76,466,292 4.388%
Puma Biotechnology Inc 205,258 48,968,401 2.810%
Amgen Inc 347,717 48,840,330 2.803%
Medivation Inc 431,077 42,620,583 2.446%
Biogen Idec Inc 122,509 40,527,202 2.326%
Intercept Pharmaceuticals Inc 168,060 39,778,121 2.283%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil